Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX | Redmile Group, LLC | 8,935 0.600% | -87,286 (-90.71%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Redmile Group, LLC | 0 0.000% | -2,416,406 (Position Closed) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Allakos Inc. ALLK | Redmile Group, LLC | 2,077,875 3.800% | -589,576 (-22.10%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 363,949 9.900% | 49,404 (+15.71%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Atreca, Inc. BCEL | Redmile Group, LLC | 800,306 2.600% | -1,675,762 (-67.68%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group, LLC | 7,265,514 9.900% | 1,535,598 (+26.80%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Redmile Group, LLC | 2,165,586 4.600% | -546,030 (-20.14%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 2,958,284 6.600% | 112,159 (+3.94%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,789,496 6.700% | 141,800 (+5.36%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | Redmile Group, LLC | 1,346,058 3.500% | -1,486,830 (-52.48%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS | Redmile Group, LLC | 0 0.000% | -2,012,900 (Position Closed) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Redmile Group, LLC | 1,954,420 6.300% | 1,954,420 (New Position) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group, LLC | 2,587,730 5.000% | -132,759 (-4.88%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,083,501 8.600% | -304,875 (-9.00%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group, LLC | 1,897,223 4.400% | -226,269 (-10.66%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | Redmile Group, LLC | 1,885,850 2.800% | -1,892,412 (-50.09%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Achilles Therapeutics plc ACHL | Redmile Group, LLC | 2,088,089 5.100% | 2,088,089 (New Position) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | ADC Therapeutics S.A. ADCT | Redmile Group, LLC | 7,451,029 9.700% | 692,235 (+10.24%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group, LLC | 3,228,917 8.400% | -219,113 (-6.35%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group, LLC | 0 0.000% | -63,436 (Position Closed) | Filing History |